4.7 Article

Salmon Calcitonin Exerts an Antidepressant Effect by Activating Amylin Receptors

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Effect of depression and suicidal behavior on neuropeptide Y (NPY) and its receptors in the adult human brain: A postmortem study

Anuradha Sharma et al.

Summary: The study investigated the role of the NPY system in depression and suicidal behavior, identifying significant decrease in NPY mRNA and upregulation of NPY1R and NPY2R mRNA in DS subjects, along with decreased NPY protein expression in the PFC. These findings provide evidence of alterations in the NPY system related to stress response in depression and suicidal behavior in humans, with potential implications for novel treatment approaches targeting the NPY system.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2022)

Article Pharmacology & Pharmacy

Pharmacological characterisation of mouse calcitonin and calcitonin receptor-like receptors reveals differences compared with human receptors

Michael L. Garelja et al.

Summary: The pharmacology of the mouse CLR/CTR and RAMPs receptors differs from that of humans, with mouse receptors showing reduced discrimination between ligands, posing challenges for interpreting data in preclinical models and translating findings from mice to humans. New ligands are needed to differentiate between these complexes.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Clinical Neurology

Exploring the role of neuropeptides in depression and anxiety

Tarapati Rana et al.

Summary: Depression is a common mental disorder with significant social and economic impacts. Finding new treatment strategies, particularly targeting neuropeptides, has become crucial in neurobiology.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2022)

Article Biochemistry & Molecular Biology

Programmed cell death 4 as an endogenous suppressor of BDNF translation is involved in stress-induced depression

Yuan Li et al.

Summary: This study revealed that Pdcd4 acts as an endogenous inhibitor for BDNF translation and provided a novel approach for enhancing BDNF expression by blocking Pdcd4 function. These findings suggest that targeting Pdcd4 may be a promising strategy for treating depressive disorders.

MOLECULAR PSYCHIATRY (2021)

Review Neurosciences

An amylin and calcitonin receptor agonist modulates alcohol behaviors by acting on reward-related areas in the brain

Aimilia Lydia Kalafateli et al.

Summary: Alcohol activates reward-processing brain areas causing stimulatory behavioral responses, while sCT attenuates alcohol-mediated behaviors when infused into the laterodorsal, ventral tegmental, and nucleus accumbens regions, indicating an inhibitory effect on alcohol-induced behaviors.

PROGRESS IN NEUROBIOLOGY (2021)

Article Immunology

Ibrutinib alleviates LPS-induced neuroinflammation and synaptic defects in a mouse model of depression

Weifen Li et al.

Summary: The study demonstrated that ibrutinib has potential anti-depressive effects by reducing neuroinflammation and synaptic defects in a mouse model of LPS-induced depression. Ibrutinib treatment inhibited NF-kB activation and proinflammatory cytokine levels, and improved synaptic markers in the hippocampus, suggesting its antidepressant potential against inflammation-induced depression.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Article Multidisciplinary Sciences

Repeated exposure with short-term behavioral stress resolves pre-existing stress-induced depressive-like behavior in mice

Eun-Hwa Lee et al.

Summary: This study demonstrates that repeated exposure to short-term stress can reverse depressive-like behavior induced by chronic stress. The anti-depressive effects of short-term stress can be mimicked by repeated injection of low doses of glucocorticoids. Additionally, both short-term stress exposure and glucocorticoid injection activate neurons in overlapping brain regions and reverse stress-induced gene expression profiles.

NATURE COMMUNICATIONS (2021)

Article Clinical Neurology

Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine-preventive medications in the phase 3b FOCUS study

Egilius L. H. Spierings et al.

Summary: The study assessed the patient-reported outcomes (PROs) in terms of quality of life, depression, and work productivity during the treatment with fremanezumab in patients with migraine, showing progressive improvements in these aspects over a 6-month period.

HEADACHE (2021)

Article Behavioral Sciences

Intranasal Neuropeptide Y as a Potential Therapeutic for Depressive Behavior in the Rodent Single Prolonged Stress Model in Females

Roxanna J. Nahvi et al.

Summary: Gender plays a significant role in susceptibility to stress-induced disorders, with women being more likely to develop conditions like PTSD following exposure to trauma. Studies suggest that females may require higher doses of neuropeptide Y (NPY) than males to achieve therapeutic effects when facing stress-triggered impairments.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2021)

Article Pharmacology & Pharmacy

Salmon Calcitonin Attenuates Some Behavioural Responses to Nicotine in Male Mice

Cajsa Aranas et al.

Summary: The study shows that the amylinergic pathway regulates certain nicotine-induced behaviors but does not affect nicotine-induced reward acquisition and expression. Additionally, the results demonstrate that sCT blocks nicotine's stimulatory effects and dopamine release, while preventing its impact on locomotor sensitization.

FRONTIERS IN PHARMACOLOGY (2021)

Article Neurosciences

Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice

Hannah Louise Zakariassen et al.

NEUROPHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Activation of amylin receptors attenuates alcohol-mediated behaviours in rodents

Aimilia Lydia Kalafateli et al.

ADDICTION BIOLOGY (2019)

Article Neurosciences

CGRP in a gene-environment interaction model for depression: effects of antidepressant treatment

Francesco Angelucci et al.

ACTA NEUROPSYCHIATRICA (2019)

Article Neurosciences

An amylin analogue attenuates alcohol-related behaviours in various animal models of alcohol use disorder

Aimilia Lydia Kalafateli et al.

NEUROPSYCHOPHARMACOLOGY (2019)

Review Pharmacology & Pharmacy

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

Panos Zanos et al.

PHARMACOLOGICAL REVIEWS (2018)

Review Pharmacology & Pharmacy

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

Debbie L. Hay et al.

BRITISH JOURNAL OF PHARMACOLOGY (2018)

Article Neurosciences

Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior

Elizabeth G. Mietlicki-Baase et al.

NEUROPHARMACOLOGY (2017)

Article Endocrinology & Metabolism

Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog

Sofie Gydesen et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2017)

Review Psychiatry

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression

D. Jeffrey Newport et al.

AMERICAN JOURNAL OF PSYCHIATRY (2015)

Article Multidisciplinary Sciences

Calcitonin gene-related peptide pre-administration acts as a novel antidepressant in stressed mice

Narumi Hashikawa-Hobara et al.

SCIENTIFIC REPORTS (2015)

Article Pharmacology & Pharmacy

Evaluation of Bone Targeting Salmon Calcitonin Analogues in Rats Developing Osteoporosis and Adjuvant Arthritis

Krishna H. Bhandari et al.

CURRENT DRUG DELIVERY (2015)

Article Neurosciences

Amylin Modulates the Mesolimbic Dopamine System to Control Energy Balance

Elizabeth G. Mietlicki-Baase et al.

NEUROPSYCHOPHARMACOLOGY (2015)

Article Multidisciplinary Sciences

Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias

Kim Vietz Andreassen et al.

PLOS ONE (2014)

Article Neurosciences

Amylin Receptor Signaling in the Ventral Tegmental Area is Physiologically Relevant for the Control of Food Intake

Elizabeth G. Mietlicki-Baase et al.

NEUROPSYCHOPHARMACOLOGY (2013)

Article Psychiatry

Animal models of anxiety disorders and stress

Alline C. Campos et al.

REVISTA BRASILEIRA DE PSIQUIATRIA (2013)

Article Neurosciences

NADPH Oxidase Mediates Depressive Behavior Induced by Chronic Stress in Mice

Ji-Seon Seo et al.

JOURNAL OF NEUROSCIENCE (2012)

Review Medicine, General & Internal

Treatment-resistant depression: therapeutic trends, challenges, and future directions

Khalid Saad Al-Harbi

PATIENT PREFERENCE AND ADHERENCE (2012)

Review Neurosciences

Behavioral animal models of depression

Hua-Cheng Yan et al.

NEUROSCIENCE BULLETIN (2010)

Article Biochemistry & Molecular Biology

Structural determinants of salmon calcitonin bioactivity -: The role of the Leu-based amphipathic α-helix

Giuseppina Andreotti et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Pharmacology & Pharmacy

Pharmacokinetics of modified oral calitonin product in health volunteers

CM Chin et al.

PHARMACOTHERAPY (2004)

Article Biochemistry & Molecular Biology

Binding of a candidate splice regulator to a calcitonin-specific splice enhancer regulates calcitonin/CGRP pre-mRNA splicing

TP Coleman et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2003)

Review Pharmacology & Pharmacy

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

A Holmes et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2003)

Review Clinical Neurology

Calcitonin gene-related peptide and calcitonin in the CSF of patients with dementia and depression - Possible disease markers

AA Mathe et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)